Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 16, 2007

Progen Employs Quintiles to Assist with Phase III Trial of Oncology Therapy

  • Progen Pharmaceuticals (www.progen. com.au) will use Quintiles’ (www.quintiles.com) services for clinical development-related projects. This agreement includes the execution of the Phase III trial of anticancer drug PI-88 for the treatment of primary liver cancer (hepatocellular carcinoma). Progen says that it is on track to initiate recruitment in the fourth quarter of 2007.


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »